Skip main navigation

Preclinical and Drug Discovery CRO

REPROCELL Biopta’s human tissue technology predicts clinical success by using the closest possible model of drug behavior in humans.

Human tissue testing is a translational approach to drug discovery that bridges the gap between animal studies and clinical trials — increasing clinical success rates and adding commercial value to preclinical drug assets through proof of concept in patient-derived living tissues.

Drug Discovery Assay Catalog

 

REPROCELL Biopta™ – the human tissue experts

Trusted by 24 of the top 25 Pharma companies

Drug Discovery Assay Catalog

REPROCELL Biopta is home to the world’s first and largest human fresh tissue assay catalog. In this digital platform, you can filter our assays by tissue type, endpoint, receptor, platform technology, drug type, and more.

Browse Our Full Catalog

Drug Discovery Assays index page

Browse by Assay Type

This invaluable information allows you to make ‘go’ or ‘no-go’ decisions with greater confidence, based on human data generated in biospecimens sourced from the target patient population.

Browse Our Human Tissue Assays

Examples of Our Work

Our expertise in all areas of human tissue testing – including ethics, sourcing, handling, and fee-for-service experiments in human fresh tissue – allows us to act as your human tissue research department.

Lindsey and Amna  at microscopes

Achieve Regulatory Approval

When IPM approached the regulators for approval of their HIV prevention ring, they requested additional data on uterine contractility. Find out how our studies in fresh human uterine tissue helped IPM gain approval.

Read the IPM case study

skin biopsies

Avoid Species Differences

Read our case study on Amgen's publication, which highlights the useful comparisons that can be made between matched tissues from preclinical species and humans.

Read the Amgen case study

Pipetting at wire myographs

Eliminate Clinical Adverse Effects

Adverse effects may go undetected during preclinical safety assessments and only become apparent during clinical trials. In most cases, such adverse effects in humans were not observed in animal models.

Read the Roche case study